Increased detection sensitivity for KRAS mutations enhances the prediction of anti-EGFR monoclonal antibody resistance in metastatic colorectal cancer.
Molinari F et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2011